Healthcare Business Management Association - HBMA
Leading the Business of Healthcare Login
Coronavirus Disease (COVID-19) Coronavirus Disease (COVID-19) - HBMA Healthcare Business Management Association

Coronavirus Disease (COVID-19) Update


White House and Federal Agencies

  • CMS announced that Medicare will pay an additional $35 for vaccines administered in a patient’s home.
  • Surgeon General Dr. Vivek Murthy participated in an interview about the COVID-19 response going forward. 
  • OSHA released a new workplace safety regulation to protect frontline healthcare workers and other workers from COVID-19.  
  • The CDC and State Department downgraded the “Do Not Travel” warning to a lower warning level for dozens of countries.

Centers for Disease Control and Prevention (CDC) Updates

Economy, Vaccines, Testing and Treatment

  • It appears increasingly unlikely that the U.S. will achieve President Biden’s goal of having 70 percent of Americans with at least one COVID-19 vaccine dose by July 4th.
  • Moderna asked the FDA to authorize its vaccine for adolescents ages 12-17.
  • The FDA approved an extended shelf life for Johnson & Johnson’s (J&J) COVID-19 vaccine ahead of thousands of doses facing expiration before this extension.
  • The Department of Defense (DOD) and FEMA will begin phasing out the mass vaccination sites they have been operating.
  • States are beginning to phase out enhanced unemployment benefits.
  • The U.S. purchased 500 million more doses of Pfizer’s COVID-19 vaccine which it will distribute to other countries. The U.S. is also in discussions with Moderna to purchase 500 million doses of its vaccine for the same purpose.
  • The World Health Organization (WHO) believes a global vaccination rate of 80 percent is needed to prevent the proliferation of new COVID-19 variants.
    • NIAID Director Anthony Fauci gave remarks to the same effect.
  • The World Trade Organization (WTO) will begin considering proposals for how it could waive international intellectual property (IP) protections for COVID-19 vaccines.
  • The J&J vaccine is showing positive results against certain variants.
  • The U.S. will purchase 1.7 million doses of Merck & Co.’s COVID-19 treatment.
  • New research shows that a single dose of the Pfizer vaccine is only 51 percent effective.
  • Canada could loosen its travel restrictions with the U.S. as early as June 22nd.